Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the analgesic efficacy and safety of HYD
tablets 20 to 120 mg once-daily dose compared to placebo in subjects with moderate to severe
chronic low back pain uncontrolled by their current stable analgesic regimen